Establishment of two basal-like breast cancer cell lines with extremely low tumorigenicity from Taiwanese premenopausal women

Human Cell
Wen-Ling KuoChi-Neu Tsai

Abstract

The research of carcinogenetic mechanisms of breast cancer in different ethnic backgrounds is an interesting field, as clinical features of breast cancers vary among races. High premenopausal incidence is distinctive in East-Asian breast cancer. However, human cell lines derived from Asian primary breast tumor are rare. To provide alternative cell line models with a relevant genetic background, we aimed to establish breast cancer cell lines from Taiwanese patients of Han-Chinese ethnicity. Fresh tissue from mammary tumors were digested into organoids, plated and grown in basal serum-free medium of human mammary epithelial cells (HuMEC) with supplements. Cells were further enriched by positive selection with CD326 (epithelial cell adhesion molecule; EpCAM)-coated micro-magnetic beads. Two breast cancer cell lines derived from premenopausal women were successfully established by this method, and named Chang-Gung Breast Cancer 01 (CGBC 01) and 02 (CGBC 02). These two cell lines had a similar phenotype with weak expression of estrogen receptor (ER), progesterone receptor (PR), and without amplification of receptor tyrosine protein kinase erbB-2 (HER2/neu). Genome-wide Single Nucleotide Polymorphism (SNP) array showed multiple copy ...Continue Reading

References

Jan 1, 1996·Breast Cancer Research and Treatment·H M McCallum, G W Lowther
Dec 4, 1998·British Journal of Cancer·V SpeirsS L Atkin
Jan 27, 1999·Developmental Biology·C PéchouxO W Petersen
Feb 22, 2002·International Journal of Cancer. Journal International Du Cancer·Yadong CuiTrudy L Bush
Jan 9, 2004·International Journal of Cancer. Journal International Du Cancer·Yuko MinamiShigeru Hisamichi
Feb 6, 2004·Breast Cancer Research and Treatment·Marc Lacroix, Guy Leclercq
Aug 17, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Ying-Chun ShenAnn-Lii Cheng
Jan 13, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K YonedaS Noguchi
Jul 14, 2007·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Rayna K MatsunoPaul H Levine
Feb 11, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joel S ParkerPhilip S Bernard
Jun 10, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Ching-Hung LinAnn-Lii Cheng
Jun 19, 2010·Cancer Causes & Control : CCC·Hai-Rim ShinPhilippe Autier
Aug 18, 2010·Proceedings of the National Academy of Sciences of the United States of America·Joseph H TaubeSendurai A Mani
Sep 4, 2010·Breast Cancer Research : BCR·Aleix PratCharles M Perou
Dec 15, 2010·Molecular Oncology·Aleix Prat, Charles M Perou
Sep 3, 2011·Breast Cancer Research : BCR·Deborah L Holliday, Valerie Speirs
Dec 20, 2011·Cancer Treatment Reviews·Pilar ErolesAna Lluch
Feb 2, 2012·International Journal of Breast Cancer·Parvin F PeddiCynthia Ma
Mar 13, 2012·International Journal of Cancer. Journal International Du Cancer·C R Beena DeviMarilys Corbex
Feb 9, 2013·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Patrycja GazinskaSarah E Pinder
May 25, 2013·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Jennifer R WonTorsten O Nielsen
Jul 25, 2013·Nature Reviews. Clinical Oncology·Michail Ignatiadis, Christos Sotiriou
Oct 2, 2013·Cancer Treatment Reviews·Iben KümlerDorte Lisbet Nielsen
Sep 13, 2014·Cancer Epidemiology·Anne StotterOlive Kearins
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal
Apr 15, 2015·Journal of the National Cancer Institute·Hyuna SungXiaohong R Yang
Aug 1, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J NingY Shen
Aug 19, 2015·Ecancermedicalscience·Krizia FerriniLucilla Titta

❮ Previous
Next ❯

Methods Mentioned

BETA
chemical dissociation
chip
PCR
chips
Genotyping
xenografts
flow cytometry

Software Mentioned

Chromosome Analysis Suite ( ChAS
ModFit
Genotyping [UNK]

Related Concepts

Related Feeds

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.